Zacks Investment Research·22h ago
Here's Why Labcorp Holdings (LH) is a Strong Momentum StockWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Labcorp Holdings Inc.(LH)Earnings, Financials & Key Ratios
LH•NYSE
$283.86
27.1× P/E·Price updated Jul 7, 2026
AboutLabcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.Show more
- Revenue$13.95B+7.2%
- EBITDA$2.2B+27.0%
- Net Income$877M+17.5%
- EPS (Diluted)10.46+18.3%
- Gross Margin26.75%-4.0%
- EBITDA Margin15.75%+18.4%
- Operating Margin10.87%+30.1%
- Net Margin6.28%+9.6%
- ROE10.5%+12.2%
LH Price & Volume
Labcorp Holdings Inc. (LH) stock price & volume — 10-year historical chart
Loading chart...
Resilient Diagnostic Scale Faces Persistent Margin Constraints
Investment Thesis • Updated 2026Q1
VerdictNeutral
Growth:Stable
Profitability:Moderate
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Regulatory reimbursement and LDT oversight
Key Thesis Takeaways
- Labcorp maintains a stable revenue trajectory with growth rates between 4.6% and 9.8% over the last ten quarters, supported by an aggressive acquisition strategy that has expanded total assets to $19.1 billion.
- However, the company struggles to translate this scale into consistent operating leverage, as evidenced by operating margins that have fluctuated between -4.0% and 11.2%.
- Investors should monitor the $7.0 billion goodwill concentration and the volatility in free cash flow, which complicates long-term capital allocation and dividend sustainability.
Verdict Logic
while the forward P/E of 15.07 suggests a reasonable valuation, the inconsistent free cash flow and the reliance on acquisitions to drive growth warrant caution regarding future earnings quality.
LH Growth Metrics
Labcorp Holdings Inc. (LH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years4.86%
5 Years-0.04%
3 Years5.55%
TTM7.34%
Profit CAGR
10 Years7.21%
5 Years-10.85%
3 Years-11.84%
TTM28.83%
EPS CAGR
10 Years9.2%
5 Years-8.01%
3 Years-9.17%
TTM30.22%
Return on Capital
10 Years10.22%
5 Years9.63%
3 Years7.42%
Last Year9.9%
LH Recent Earnings
Labcorp Holdings Inc. (LH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$4.25+3.4%
$4.11
Rev
$3.5B+0.8%
$3.5B
Q1 2026
Feb 17, 2026Metric
Actual
Est
EPS
$4.07+3.0%
$3.95
Rev
$3.5B-1.2%
$3.6B
Q4 2025
Oct 28, 2025Metric
Actual
Est
EPS
$4.18+1.2%
$4.13
Rev
$3.6B+0.2%
$3.6B
Q3 2025
Jul 24, 2025Metric
Actual
Est
EPS
$4.35+4.3%
$4.17
Rev
$3.5B+1.2%
$3.5B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $4.25vs $4.11+3.4% | $3.5Bvs $3.5B+0.8% |
| Q1 2026 | Feb 17, 2026 | $4.07vs $3.95+3.0% | $3.5Bvs $3.6B-1.2% |
| Q4 2025 | Oct 28, 2025 | $4.18vs $4.13+1.2% | $3.6Bvs $3.6B+0.2% |
| Q3 2025 | Jul 24, 2025 | $4.35vs $4.17+4.3% | $3.5Bvs $3.5B+1.2% |
Based on last 12 quarters of dataView full earnings history →
Latest LH News
Recent stock market news and headlines for Labcorp Holdings Inc. (LH)
Zacks Investment Research·6 days ago
LH or CRL: Which Is the Better Value Stock Right Now?Investors with an interest in Medical Services stocks have likely encountered both Labcorp Holdings (LH) and Charles River Laboratories (CRL). But which of these two companies is the best option for those looking for undervalued stocks?
PRNewsWire·Jun 30, 2026
Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026BURLINGTON, N.C., June 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on Thursday, July 30, 2026.
Zacks Investment Research·Jun 25, 2026
Is it the Right Time to Add Labcorp Stock to Your Portfolio?LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds could weigh on results.
Zacks Investment Research·Jun 25, 2026
Here's Why Labcorp Holdings (LH) is a Strong Value StockWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Peers Comparison
Key metrics vs top competitors for Labcorp Holdings Inc. (LH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $283.86 | $23.36B | 27.14 | 7.25% | 6.28% | 10.5% | 1.01% | |
| $212.38 | $23.51B | 24.27 | 11.78% | 9.08% | 13.8% | — | |
| $53.01 | $2.76B | 135.92 | — | 33.7% | 22.86% | — | |
| $104.91 | $20.02B | -95.37 | 17.69% | -6.4% | -8.66% | — | |
| $292.50 | $7.9B | 10.50 | 0.65% | 6.52% | 2.4% | — | |
| $281.27 | $40.28B | -185.05 | 35.9% | -9.05% | -15.13% | — |
Compare LH vs Peers
Labcorp Holdings Inc. (LH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LH SEC Filings & Documents
Labcorp Holdings Inc. (LH) SEC filings — annual & quarterly reports (10-K, 10-Q)
8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Apr 9, 2026·SEC
Material company update
Mar 31, 2026·SEC
10-K Annual Reports
210-Q Quarterly Reports
3Get notified when LH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
LH Frequently Asked Questions
Labcorp Holdings Inc. (LH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Labcorp Holdings Inc.'s revenue?
Labcorp Holdings Inc. (LH) reported $14.14B in revenue for fiscal year 2025. This represents a 780% increase from $1.61B in 1996.
How fast is Labcorp Holdings Inc. growing?
Labcorp Holdings Inc. (LH) grew revenue by 7.2% over the past year. This is steady growth.
Is LH profitable?
Yes, Labcorp Holdings Inc. (LH) is profitable, generating $941.5M in net income for fiscal year 2025 (6.3% net margin).
Dividend & Returns
Does LH pay dividends?
Yes, Labcorp Holdings Inc. (LH) pays a dividend with a yield of 1.01%. This makes it attractive for income-focused investors.
What is LH's return on equity?
Labcorp Holdings Inc. (LH) has a return on equity (ROE) of 10.5%. This is reasonable for most industries.
What is Labcorp Holdings Inc.'s free cash flow?
Labcorp Holdings Inc. (LH) generated $1.38B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.